Journal of the American Society of Echocardiography
Volume 14, Issue 8 , Pages 789-797, August 2001

Radiofrequency spectral analysis of attenuated ultrasound signals in experiments with echo contrast microbubbles

Division of Cardiovascular Diseases and Internal Medicine and Department of Physiology and Biophysics, Mayo Clinic, Rochester, Minn. Rochester, Minnesota

Correspondence: Marek Belohlavek, MD, PhD, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Abstract 

Conventional gray-scale myocardial contrast echocardiography cannot distinguish perfused but attenuated from nonperfused myocardium because both may appear similar at low image intensity. We hypothesized that with radiofrequency spectral analysis of attenuated ultrasound signals, the harmonic-to-fundamental frequency ratio of the peak power spectrum (HFRP) could determine the presence of contrast microbubbles. We measured frequency responses of Optison microbubbles at defined degrees of ultrasound signal attenuation with different formulations of silicone (55D, 80A, and 3M); gray-scale intensities of Optison plus water compared with degassed water were analyzed at different attenuation settings (−25, −32, and −44 dB, respectively). HFRP values of Optison plus water were significantly higher than reference values of degassed water at each attenuation setting (55D, −14 ± 2 dB versus −30 ± 2 dB, P < .001; 80A, −19 ± 2 dB versus −30 ± 3 dB, P < .01; 3M, −22 ± 2 dB versus −30 ± 3 dB, P < .05), even though conventional videodensitometric analysis could not distinguish them. HFRP analysis objectively detects microbubbles in clinically relevant conditions of attenuation. (J Am Soc Echocardiogr 2001;14:789-97.)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Nothing in this publication implies that Mayo Foundation endorses any products of Mallinckrodt Medical.

PII: S0894-7317(01)17323-2

Journal of the American Society of Echocardiography
Volume 14, Issue 8 , Pages 789-797, August 2001